Hackensack University Medical Center
Internal Medicine residency · Hackensack, NJ · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Hackensack University Medical Center's research in internal medicine, which the program shares with other departments and affiliated hospitals.
About Hackensack University Medical Centerinstitution-wide internal medicine research
Internal Medicine publications from Hackensack University Medical Center and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
147
works per year
88th of 129 internal medicine residency programs
+10.0%
2-year growth
57th of 129 internal medicine residency programs
24.4%
in top 10% of field (works before 2025)
58th of 120 internal medicine residency programs
38.9%
cited above world average
76th of 120 internal medicine residency programs
Works per year · * 2026 so far
Hematology · 180Oncology · 172Cardiology and Cardiovascular Medicine · 148Pulmonary and Respiratory Medicine · 83Infectious Diseases · 46
Internal Medicine research topics at Hackensack University Medical Center
Papers in the window; each links to the list on OpenAlex.
- Multiple Myeloma Research and Treatments 66
- CAR-T cell therapy research 58
- Hematopoietic Stem Cell Transplantation 53
- Cancer Immunotherapy and Biomarkers 47
- Cardiac Valve Diseases and Treatments 46
- Atrial Fibrillation Management and Outcomes 31
- Acute Myeloid Leukemia Research 30
- COVID-19 Clinical Research Studies 28
Most cited at Hackensack University Medical Center since 2024
All internal medicine papers there on OpenAlex
- Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b studyJeffrey S. Weber et al. · The Lancet · 2024 · PubMed · cited 958
- Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled TrialWissam A. Jaber et al. · Circulation · 2024 · PubMed · cited 226
- 2024 American College of Rheumatology ( ACR ) Guideline for the Screening, Treatment, and Management of Lupus NephritisLisa R. Sammaritano et al. · Arthritis & Rheumatology · 2025 · PubMed · cited 147
- Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm AssociationWolfram Doehner et al. · EP Europace · 2025 · PubMed · cited 146
- Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic LeukemiaElias Jabbour et al. · JAMA · 2024 · PubMed · cited 131
- Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypesSheri Skerget et al. · Nature Genetics · 2024 · PubMed · cited 112
- 2025 American College of Rheumatology ( ACR ) Guideline for the Treatment of Systemic Lupus ErythematosusLisa R. Sammaritano et al. · Arthritis Care & Research · 2025 · PubMed · cited 67
- An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphomaSandeep S. Raj et al. · Nature Medicine · 2025 · PubMed · cited 64
- 2024 American College of Rheumatology ( ACR ) Guideline for the Screening, Treatment, and Management of Lupus NephritisLisa R. Sammaritano et al. · Arthritis Care & Research · 2025 · PubMed · cited 61
- Ziftomenib in Relapsed or Refractory NPM1 -Mutated AMLEunice S. Wang et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 58